<?xml version="1.0" encoding="UTF-8"?>
<p id="par0020">Food and Drug Administration (FDA) has worked out on a guidance to provide recommendations to health care providers and investigators on COVID-19 Convalescent Plasma (CCP) during the public health emergency. In this guide, it is recalled that immune plasma has already been studied in other respiratory infections in the past twenty years and stated that the use of CCP might be effective against the infection based on those experiences [
 <xref rid="bib0040" ref-type="bibr">8</xref>].
</p>
